Identification of human herpesvirus 8-specific cytotoxic T-cell responses

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 6136-6140

  Osman, Mohamed ^b,c   Kubo, Toru ^b   Gill, Jasjit ^b   Neipel, Frank ^a   Becker, Marion ^d   Smith, Geoffrey ^d   Weiss, Robin ^c   Gazzard, Brian ^b   Boshoff, Chris ^c,e   Gotch, Frances ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HAMSTER; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS GENE;

EID: 0033031427     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.6136-6140.1999     Document Type: Article

References (35)

1. Boshoff, C., S.-J. Gao, L. E. Healy, S. Matthews, A. J. Thomas, L. Colgnet, R. A. Warnke, J. A. Strauchen, E. Matutes, O. W. Kamel, P. S. Moore, R. A. Weiss, and Y. Chang. 1998. Establishment of a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in vivo. Blood 91:1671-1679.
2. Boshoff, C., and R. A. Weiss. 1998. Kaposi's sarcoma-associated herpesvirus, p. 57-86. In G. Vande Woude and G. Klein (ed.), Advances in cancer research, vol. 75. Academic Press, San Diego, Calif.
3. Carroll, M., and B. Moss. 1997. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in non-human mammalian cell line. Virology 238:198-211.
4. Cesarman, E., and D. Knowles. 1999. Lymphoproliferations associated with KSHV, p. 165-174. In C. Boshoff and R. A. Weiss (ed.), Seminars in cancer biology, vol. 9. Academic Press, London, England.
5. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
6. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
7. Chang, Y., and P. S. Moore. 1996. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect. Agents Dis. 5:215-222.
8. Dupin, N., C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. Van Marck, D. Salmon, I. Gorin, J.-P. Escande, R. A. Weiss, K. Alitalo, and C. Boshoff. 1999. Distribution of HHV-8 positive cells in Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. Proc. Natl. Acad. Sci. USA 96:4546-4551.
9. Epstein, M. A. 1986. Vaccination against Epstein-Barr virus: current progress and future strategies. Lancet i:1425-1427.
10. Gallo, R. C. 1998. The enigmas of Kaposi's sarcoma. Science 282:1837-1839.
11. Ganem, D. 1997. KSHV and Kaposi's sarcoma: the end of the beginning. Cell 91:157-160.
12. Gao, S. J., L. Kingsley, M. Li, W. Zheng, C. Parravicini, J. Ziegler, R. Newton, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, Y. Chang, and P. S. Moore. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2:925-928.
13. Gotch, F., and K. Broliden. 1995. HIV-1 specific cytotoxic T lymphocytes and ADCC responses, p. 253-271. In J. Kam (ed.), HIV: virology and immunology, a practical approach, vol. 1. IRL, Oxford, England.
14. Haas, G., A. Samri, E. Gomard, A. Hosmalin, J. Duntze, J. Bouley, H. Ihlenfelds, C. Katlama, and B. Autran. 1998. Cytotoxic T-cells to HIV-1 reverse transcriptase, integrase and protease. AIDS 12:1427-1436.
15. Hayward, G. S. 1999. KSHV strains: the origins and global spread of the virus, p. 187-199. In C. Boshoff and R. A. Weiss (ed.), Seminars in cancer biology, vol. 9. Academic Press, London, England.
16. Jacobson, L. P., T. E. Yamashita, R. Detels, J. B. Margolick, J. S. Chmiel, L. A. Kingsley, S. Melnick, and A. Munoz. Impact of potent anti-retroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1 infected individuals. J. Acquired Immune Defic. Syndr. Retrovirol., in press.
17. Krausa, P., J. Bodmer, and M. Browning. 1993. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 42:91-99.
18. Lagunoff, D., and D. Ganem. 1997. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). Virology 236:147-154.
19. Lee, H., R. Veazey, K. Williams, M. Li, J. Guo, F. Neipel, B. Fleckenstein, A. Lackner, R. C. Desrosiers, and J. U. Jung. 1998. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat. Med. 4:435-440.
20. Li, M., J. MacKey, S. C. Czajak, R. C. Desrosiers, A. A. Lackner, and J. U. Jung. 1999. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J. Virol. 73:1341-1349.
21. Muralidhar, S., A. M. Pumfery, M. Hassani, M. R. Sadaie, N. Azumi, M. Kishishita, J. N. Brady, J. Doniger, P. Medveczky, and L. J. Rosenthal. 1998. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72: 4980-4988.
22. Nicholas, J., Z. Jian-Chao, D. J. Alcendor, D. M. Ciufo, L. J. Poole, R. T. Sarisky, C.-J. Chiou, X. Zhang, X. Wan, H.-G. Guo, M. S. Reirz, and G. S. Hayward. 1998. Novel organization features, captured cellular genes, and strain variability within the genome of KSHV/HHV-8. J. Natl. Cancer Inst. 23:79-88.
23. Pepperl, S., G. Benninger-Döring, S. Modrow, H. Wolf, and W. Jilg. 1998. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. J. Virol. 72:8644-8649.
24. Raab, M.-S., J.-C. Albrecht, A. Birkmann, S. Yaǧuboǧlu, D. Lang, B. Fleckenstein, and F. Neipel. 1998. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:6725-6731.
25. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2447. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed, vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
26. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-431.
27. Rooney, C. M., C. A. Smith, C. Y. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9-13.
28. Sitas, F., H. Carrara, V. Beral, R. Newton, G. Reeves, D. Bull, M. Retter, B. Fine, R. Pacella-Norman, D. Bourboulia, D. Whitby, C. Boshoff, and R. Weiss. The seroepidemiology of HHV-8/KSHV in a large population of black cancer patients in Johannesburg. N. Engl. J. Med., in press.
29. Soulier, J., L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals Hatem, P. Babinet, M. F. d'Agay, J. P. Clauvel, M. Raphael, and L. Degos. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 84:1276-1280.
30. Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, and A. T. Haase. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
31. Steven, N. M., N. E. Annels, A. Kumar, A. M. Leese, M. G. Kurilla, and A. B. Rickinson. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1605-1617.
32. Tanner, J., J. Weis, D. Fearon, Y. Whang, and E. Keiff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203-213.
33. Whitby, D., M. R. Howard, M. Tenant Flowers, N. S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. E. Suggett, D. M. Aldam, A. S. Denton, R. F. Miller, I. V. D. Weller, R. A. Weiss, R. S. Tedder, and T. F. Schulz. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802.
34. Whitby, D., M. Luppi, P. Barozzi, C. Boshoff, R. A. Weiss, and G. Torelli. 1998. HHV-8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J. Natl. Cancer Inst. 90:395-397.
35. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 93:6641-6646.